Pictured: Charles Sawyers
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Pictured: Liang Deng
Profile
By Jim Stallard, MA, Writer/Editor  |  Friday, April 26, 2013

Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers, and also conducts innovative research on poxviruses.

Pictured: Guido Dalbagni
Video
By Memorial Sloan Kettering  |  Tuesday, April 23, 2013

Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan Kettering, which can help patients maintain their quality of life.

Pictured: Gary Schwartz & Mark Dickson
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan Kettering investigators show promising results against different types of sarcoma.

Pictured: CinemaVision goggles
Feature
By Celia Gittelson, BA  |  Friday, April 19, 2013

The Society of MSKCC’s Patient Environment Program funds projects aimed at enriching Memorial Hospital’s physical environment and the comfort of our patients.

Pictured: Andrew Vickers
Finding
By Allyson Collins, MS, Science Writer/Editor  |  Wednesday, April 17, 2013

A study led by Memorial Sloan Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Pictured: Megan Harlan Fleischut & Kenneth Offit
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 15, 2013

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan Kettering’s clinical genetics experts.

Pictured: Virtual Groups
Event
By Julie Grisham, MS, Science Writer/Editor  |  Friday, April 12, 2013

Memorial Sloan Kettering’s Virtual Groups program offers patients private, online support and education sessions to participate in from home or work.

Pictured: Dan Douer
Video
By Memorial Sloan Kettering  |  Wednesday, April 10, 2013

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

Pictured: José Baselga
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 8, 2013

Memorial Sloan Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Pictured: Jedd Wolchok
In the Clinic
By Media Staff  |  Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Pictured: Marc Ladanyi & Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, April 3, 2013

A new guideline has established standards for testing lung cancer tumors for genetic abnormalities, giving more patients a chance to benefit from targeted therapies.

Pictured: Paul Sabbatini
Q&A
By Media Staff  |  Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan Kettering’s clinical research program.

Pictured: Kenneth Offit
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Pictured: Yukio Sonoda
Video
By Memorial Sloan Kettering  |  Wednesday, March 27, 2013

Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan Kettering have the benefit of an entire team of physicians having input into their care.

Center News

Stay Informed

Get the latest information about cancer care and research every month.